Measles clinical trials

Explore recruiting measles clinical trials.

Recruiting measles studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Measles trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The induction of respiratory immune responses by epicutaneous vaccination with the MMR vaccine

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

EarLy extra Measles immunisation during a measles Outbreak (ELMO)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Measles-mumps-rubella vaccine (MMR) at 6 months of age: Long-term follow-up

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Phase II, single-blind, randomized, controlled study to evaluate the immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4 to 6 years of age

Latvia, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Measles trials by city

Measles in Toronto Measles in Vancouver Measles in Montreal Measles in Calgary Measles in Edmonton Measles in Ottawa Measles in Winnipeg Measles in Quebec City Measles in Hamilton Measles in Kitchener Measles in London Measles in Halifax Measles in New York Measles in Los Angeles Measles in Chicago Measles in Houston

Measles clinical trials

Recruiting measles studies right now

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Measles and BCG Vaccines for Mother and Child

Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients

Also recruiting in Europe

The induction of respiratory immune responses by epicutaneous vaccination with the MMR vaccine

EarLy extra Measles immunisation during a measles Outbreak (ELMO)

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Measles-mumps-rubella vaccine (MMR) at 6 months of age: Long-term follow-up

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

A Phase II, single-blind, randomized, controlled study to evaluate the immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4 to 6 years of age

Measles trials by city

Other conditions